Carevive SMART Data – EVALUATE

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly, the invaluable trends that longitudinal real-world data sets can reveal about the patient experience. Lastly, how digital tools empower clinicians to predict and manage the experiences of cancer patients more effectively.

With a comprehensive approach, Carevive is transforming cancer care by harnessing the power of patient experience insights. Join us on this transformative journey as we continue to make a positive impact on the lives of cancer patients and their healthcare providers. Together, we build a brighter future for cancer care, one step at a time.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…